Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Vorsetuzumab_mafodotin> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- Vorsetuzumab_mafodotin abstract "Vorsetuzumab mafodotin (SGN-75) is an antibody-drug conjugate (ADC) directed to the protein CD70 designed for the treatment of cancer. It is a humanized monoclonal antibody, vorsetuzumab, conjugated with noncleavable monomethyl auristatin F (MMAF), a cytotoxic agent.This drug was developed by Seattle Genetics, Inc. The drug completed phase I clinical trials for renal cell carcinoma, but development was discontinued.".
- Vorsetuzumab_mafodotin atcPrefix "none".
- Vorsetuzumab_mafodotin casNumber "1165741-01-4".
- Vorsetuzumab_mafodotin wikiPageID "36131810".
- Vorsetuzumab_mafodotin wikiPageLength "2015".
- Vorsetuzumab_mafodotin wikiPageOutDegree "10".
- Vorsetuzumab_mafodotin wikiPageRevisionID "601668740".
- Vorsetuzumab_mafodotin wikiPageWikiLink Antibody-drug_conjugate.
- Vorsetuzumab_mafodotin wikiPageWikiLink CD70.
- Vorsetuzumab_mafodotin wikiPageWikiLink Cancer.
- Vorsetuzumab_mafodotin wikiPageWikiLink Category:Monoclonal_antibodies.
- Vorsetuzumab_mafodotin wikiPageWikiLink Cytotoxic_agent.
- Vorsetuzumab_mafodotin wikiPageWikiLink Cytotoxicity.
- Vorsetuzumab_mafodotin wikiPageWikiLink Monomethyl_auristatin_F.
- Vorsetuzumab_mafodotin wikiPageWikiLink Renal_cell_carcinoma.
- Vorsetuzumab_mafodotin wikiPageWikiLink Seattle_Genetics.
- Vorsetuzumab_mafodotin wikiPageWikiLink Vorsetuzumab.
- Vorsetuzumab_mafodotin wikiPageWikiLinkText "Vorsetuzumab mafodotin".
- Vorsetuzumab_mafodotin wikiPageWikiLinkText "vorsetuzumab mafodotin".
- Vorsetuzumab_mafodotin atcPrefix "none".
- Vorsetuzumab_mafodotin casNumber "1165741".
- Vorsetuzumab_mafodotin chemicalFormula "C6476H10006N1726O2028S503-5".
- Vorsetuzumab_mafodotin chemspiderid "NA".
- Vorsetuzumab_mafodotin hasPhotoCollection Vorsetuzumab_mafodotin.
- Vorsetuzumab_mafodotin legalStatus "Discontinued".
- Vorsetuzumab_mafodotin molecularWeight "150".
- Vorsetuzumab_mafodotin source "zu/o".
- Vorsetuzumab_mafodotin synonyms "SGN-75".
- Vorsetuzumab_mafodotin target CD70.
- Vorsetuzumab_mafodotin type "mab".
- Vorsetuzumab_mafodotin wikiPageUsesTemplate Template:Drugbox.
- Vorsetuzumab_mafodotin wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Vorsetuzumab_mafodotin wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Vorsetuzumab_mafodotin subject Category:Monoclonal_antibodies.
- Vorsetuzumab_mafodotin hypernym Conjugate.
- Vorsetuzumab_mafodotin type Article.
- Vorsetuzumab_mafodotin type ChemicalSubstance.
- Vorsetuzumab_mafodotin type Drug.
- Vorsetuzumab_mafodotin type Antibody.
- Vorsetuzumab_mafodotin type Article.
- Vorsetuzumab_mafodotin type Chemical.
- Vorsetuzumab_mafodotin type Drug.
- Vorsetuzumab_mafodotin type ChemicalObject.
- Vorsetuzumab_mafodotin type Thing.
- Vorsetuzumab_mafodotin type Q8386.
- Vorsetuzumab_mafodotin comment "Vorsetuzumab mafodotin (SGN-75) is an antibody-drug conjugate (ADC) directed to the protein CD70 designed for the treatment of cancer. It is a humanized monoclonal antibody, vorsetuzumab, conjugated with noncleavable monomethyl auristatin F (MMAF), a cytotoxic agent.This drug was developed by Seattle Genetics, Inc. The drug completed phase I clinical trials for renal cell carcinoma, but development was discontinued.".
- Vorsetuzumab_mafodotin label "Vorsetuzumab mafodotin".
- Vorsetuzumab_mafodotin sameAs m.0k0rf2q.
- Vorsetuzumab_mafodotin sameAs Q7941885.
- Vorsetuzumab_mafodotin sameAs Q7941885.
- Vorsetuzumab_mafodotin wasDerivedFrom Vorsetuzumab_mafodotin?oldid=601668740.
- Vorsetuzumab_mafodotin isPrimaryTopicOf Vorsetuzumab_mafodotin.